Nanoknife And Hepatic Embolization For Colorectal Cancer Liver Metastases

dc.creatorCruz M.R.S.
dc.creatorDe Lima Lopes G.
dc.creatorDos Santos L.V.
dc.date2014
dc.date2015-06-25T17:53:23Z
dc.date2015-11-26T14:23:34Z
dc.date2015-06-25T17:53:23Z
dc.date2015-11-26T14:23:34Z
dc.date.accessioned2018-03-28T21:25:35Z
dc.date.available2018-03-28T21:25:35Z
dc.identifier
dc.identifierCurrent Colorectal Cancer Reports. Current Science Ltd, v. 10, n. 1, p. 76 - 83, 2014.
dc.identifier15563790
dc.identifier10.1007/s11888-013-0202-5
dc.identifierhttp://www.scopus.com/inward/record.url?eid=2-s2.0-84896549116&partnerID=40&md5=749b8478b3975ae0cf5fa80a0e559c7b
dc.identifierhttp://www.repositorio.unicamp.br/handle/REPOSIP/86438
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/86438
dc.identifier2-s2.0-84896549116
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1245152
dc.descriptionEffective techniques for local management of unresectable colorectal liver metastases are important tools for a substantial number of patients. Novel approaches and technical improvement of older techniques have been developed to target liver lesions, both in the combined-modality and salvage settings. Irreversible electroporation is a non-thermal technique and can be safely delivered to lesions in the margins of blood vessels, with low risk of vascular disruption. Hepatic embolization consists of selectively treating a hepatic tumor, via its nutrient arterial supply, with one of the following technical variations: bland embolization, chemoembolization, or radioembolization. These techniques have achieved locoregional disease control activity that ultimately may translate into survival gains. Both modalities should be considered as an option for selected patients with colorectal cancer liver metastases. © 2014 Springer Science+Business Media.
dc.description10
dc.description1
dc.description76
dc.description83
dc.descriptionSiegel, R., Naishadham, D., Jemal, A., Cancer statistics, 2013 (2013) CA: Cancer J Clin., 63, pp. 11-30
dc.descriptionAlberts, S.R., Poston, G.J., Treatment advances in liver-limited metastatic colorectal cancer (2011) Clin Colorectal Cancer, 10, pp. 258-265
dc.descriptionMcLoughlin, J.M., Jensen, E.H., Malafa, M., Resection of colorectal liver metastases: Current perspectives (2006) Cancer Control, 13 (1), pp. 32-41. , http://www.moffitt.usf.edu/pubs/ccj/v13n1/pdf/32.pdf
dc.descriptionHeinrich, S., Lang, H., Liver metastases from colorectal cancer: Technique of liver resection (2013) J Surg Oncol, 107, pp. 579-584
dc.descriptionAlbert, M., Kiefer, M.V., Sun, W., Chemoembolization of colorectal liver metastases with cisplatin, doxorubicin, mitomycin C, ethiodol, and polyvinyl alcohol (2011) Cancer, 117, pp. 343-352. , This paper shows the difference of outcomes, with increased survival rates with introduction of TACE after first or second lines of systemic therapy when compared with salvage therapy
dc.descriptionBecker, D., Hansler, J.M., Strobel, D., Hahn, E.G., Percutaneous ethanol injection and radio-frequency ablation for the treatment of nonresectable colorectal liver metastases-techniques and results (1999) Langenbeck's Arch Surg / Deutsche Gesellschaft fur Chirurgie, 384, pp. 339-343
dc.descriptionVan Tilborg, A.A., Meijerink, M.R., Sietses, C., Long-term results of radiofrequency ablation for unresectable colorectal liver metastases: A potentially curative intervention (2011) Br J Radiol, 84, pp. 556-565
dc.descriptionKennedy, T.J., Cassera, M.A., Khajanchee, Y.S., Laparoscopic radiofrequency ablation for the management of colorectal liver metastases: 10-year experience (2013) J Surg Oncol, 107, pp. 324-328
dc.descriptionDonckier, V., Van Laethem, J.-L., Ickx, B., Van Gansbeke, D., Goldman, S., Gelin, M., Local ablative treatments for liver metastases: The current situation (2003) Acta Chirurgica Belgica, 103 (5), pp. 452-457
dc.descriptionFong, Z.V., Palazzo, F., Needleman, L., Combined hepatic arterial embolization and hepatic ablation for unresectable colorectal metastases to the liver (2012) Am Surg, 78, pp. 1243-1248
dc.descriptionAhmed, M., Brace, C.L., Lee Jr., F.T., Goldberg, S.N., Principles of and advances in percutaneous ablation (2011) Radiology, 258, pp. 351-369
dc.descriptionAl-Sakere, B., Andre, F., Bernat, C., Tumor ablation with irreversible electroporation (2007) PLoS One, 2, pp. e1135
dc.descriptionBertacchini, C., Margotti, P.M., Bergamini, E., Lodi, A., Ronchetti, M., Cadossi, R., Design of an irreversible electroporation system for clinical use (2007) Technology in Cancer Research and Treatment, 6 (4), pp. 313-320
dc.descriptionGolberg, A., Yarmush, M.L., Nonthermal irreversible electroporation: Fundamentals, applications, and challenges (2013) IEEE Trans Biomed Eng, 60, pp. 707-714
dc.descriptionEdd, J.F., Horowitz, L., Davalos, R.V., Mir, L.M., Rubinsky, B., In vivo results of a new focal tissue ablation technique: Irreversible electroporation (2006) IEEE Transactions on Biomedical Engineering, 53 (7), pp. 1409-1415. , DOI 10.1109/TBME.2006.873745, 1643410
dc.descriptionLee, E.W., Chen, C., Prieto, V.E., Advanced hepatic ablation technique for creating complete cell death: Irreversible electroporation (2010) Radiology, 255, pp. 426-433
dc.descriptionKim, G.B., Sung, G.K., Baik, G.Y., Changes of apoptosis in tumor tissues with time after irreversible electroporation (2013) Biochem Biophys Res Commun, 435, pp. 651-656
dc.descriptionCharpentier, K.P., Irreversible electroporation for the ablation of liver tumors: Are we there yet? (2012) Arch Surg, 147, pp. 1053-1061
dc.descriptionKingham, T.P., Karkar, A.M., D'Angelica, M.I., Ablation of perivascular hepatic malignant tumors with irreversible electroporation (2012) J Am Coll Surg, 215, pp. 379-387
dc.descriptionKosiek, O., Strach, K., Ricke, J., Pech, M., Irreversible electroporation - A new kid on the block? (2012) Radiologe, 52, pp. 38-43
dc.descriptionRyan, E.R., Sofocleous, C.T., Schoder, H., Split-dose technique for FDG PET/CT-guided percutaneous ablation: A method to facilitate lesion targeting and to provide immediate assessment of treatment effectiveness (2013) Radiology, 268, pp. 288-295
dc.descriptionThomson, K.R., Cheung, W., Ellis, S.J., Investigation of the safety of irreversible electroporation in humans (2011) J Vasc Interv Radiol, 22, pp. 611-621
dc.descriptionLoaiza-Bonilla, A., Barbery, K.J., Perez-Rojas, E., Percutaneous irreversible electroporation (IRE) in the treatment of hepatocellular carcinoma (HCC) and metastatic colorectal cancer (mCRC) to the liver: A retrospective analysis of the University of Miami experience (2012) 2012 Gastrointestinal Cancers Symposium. J Clin Oncol, 30 (SUPPL. 4), p. 291. , abstr 272
dc.descriptionBagla, S., Papadouris, D., Percutaneous irreversible electroporation of surgically unresectable pancreatic cancer: A case report (2012) J Vasc Interv Radiol, 23, pp. 142-145
dc.descriptionCannon, R., Ellis, S., Hayes, D., Safety and early efficacy of irreversible electroporation for hepatic tumors in proximity to vital structures (2013) J Surg Oncol, 107, pp. 544-549
dc.descriptionAu, J.T., Kingham, T.P., Jun, K., Irreversible electroporation ablation of the liver can be detected with ultrasound B-mode and elastography (2013) Surgery, 50, pp. 146-179
dc.descriptionLee, E.W., Loh, C.T., Kee, S.T., Imaging guided percutaneous irreversible electroporation: Ultrasound and immunohistological correlation (2007) Technol Cancer Res Treat, 6, pp. 287-294
dc.descriptionAppelbaum, L., Ben-David, E., Sosna, J., US findings after irreversible electroporation ablation: Radiologic-pathologic correlation (2012) Radiology, 262, pp. 117-125
dc.descriptionWiggermann, P., Zeman, F., Niessen, C., Percutaneous irreversible electroporation (IRE) of hepatic malignant tumours: Contrast-enhanced ultrasound (CEUS) findings (2012) Clin Hemorheol Microcirc, 52, pp. 417-427
dc.descriptionSchmidt, C.R., Shires, P., Mootoo, M., Real-time ultrasound imaging of irreversible electroporation in a porcine liver model adequately characterizes the zone of cellular necrosis (2012) HPB, 14, pp. 98-102. , Oxford
dc.descriptionGuo, Y., Zhang, Y., Nijm, G.M., Irreversible electroporation in the liver: Contrast-enhanced inversion-recovery MR imaging approaches to differentiate reversibly electroporated penumbra from irreversibly electroporated ablation zones (2011) Radiology, 258, pp. 461-468
dc.descriptionLee, Y.J., Lu, D.S., Osuagwu, F., Lassman, C., Irreversible electroporation in porcine liver: Acute computed tomography appearance of ablation zone with histopathologic correlation (2013) J Comput Assist Tomogr, 37, pp. 154-158
dc.descriptionDeodhar, A., Dickfeld, T., Single, G.W., Irreversible electroporation near the heart: Ventricular arrhythmias can be prevented with ECG synchronization (2011) AJR Am J Roentgenol, 196, pp. W330-W335
dc.descriptionFaroja, M., Ahmed, M., Appelbaum, L., Irreversible electroporation ablation: Is all the damage nonthermal? (2013) Radiology, 266, pp. 462-470
dc.descriptionAdeyanju, O.O., Al-Angari, H.M., Sahakian, A.V., The improvement of irreversible electroporation therapy using saline-irrigated electrodes: A theoretical study (2011) Technol Cancer Res Treat, 10, pp. 347-360
dc.descriptionArena, C.B., Sano, M.B., Rossmeisl Jr., J.H., High-frequency irreversible electroporation (H-FIRE) for non-thermal ablation without muscle contraction (2011) Biomed Eng Online, 10, p. 102
dc.descriptionKerr, D.J., McArdle, C.S., Ledermann, J., Taylor, I., Sherlock, D.J., Schlag, P.M., Buckels, J., Stephens, R.J., Intrahepatic arterial versus intravenous fluorouracil and folinic acid for colorectal cancer liver metastases: A multicentre randomised trial (2003) Lancet, 361 (9355), pp. 368-373. , DOI 10.1016/S0140-6736(03)12388-4
dc.descriptionGonsalves, C.F., Brown, D.B., Chemoembolization of hepatic malignancy (2009) Abdom Imaging, 34, pp. 557-565
dc.descriptionYamane, B., Weber, S., Liver-directed treatment modalities for primary and secondary hepatic tumors (2009) Surg Clin North Am, 89, pp. 97-113+ix
dc.descriptionAliberti, C., Fiorentini, G., Muzzio, P.C., Trans-arterial chemoembolization of metastatic colorectal carcinoma to the liver adopting DC Bead(R), drug-eluting bead loaded with irinotecan: Results of a phase II clinical study (2011) Anticancer Res, 31, pp. 4581-4587
dc.descriptionChen, Y., Yan, Z., Wang, J., Hepatic arterial infusion with oxaliplatin, irinotecan and doxifluridine for unresectable liver metastases of colorectal cancer (2010) Anticancer Res, 30, pp. 3045-3049
dc.descriptionFiorentini, G., Aliberti, C., Benea, G., TACE of liver metastases from colorectal cancer adopting irinotecan-eluting beads: Beneficial effect of palliative intra-arterial lidocaine and post-procedure supportive therapy on the control of side effects (2008) Hepatogastroenterology, 55, pp. 2077-2082
dc.descriptionGhanaati, H., Mohammadzadeh, V., Mohammadzadeh, A., Efficacy of transarterial chemoembolization on lesion reduction in colorectal liver metastases (2012) Acta Med Iran, 50, pp. 535-540
dc.descriptionLang, E.K., Brown Jr., C.L., Colorectal metastases to the liver: Selective chemoembolization (1993) Radiology, 189 (2), pp. 417-422
dc.descriptionLewandowski, R.J., Thurston, K.G., Goin, J.E., Wong, C.-Y.O., Gates, V.L., Van Buskirk, M., Geschwind, J.-F.H., Salem, R., 90Y microsphere (TheraSphere) treatment for unresectable colorectal cancer metastases of the liver: Response to treatment at targeted doses of 135-150 Gy as measured by [18F]fluorodeoxyglucose positron emission tomography and computed tomographic imaging (2005) Journal of Vascular and Interventional Radiology, 16 (12), pp. 1641-1651. , DOI 10.1097/01.RVI.0000179815.44868.66, PII 0000251820051200000013
dc.descriptionMulcahy, M.F., Lewandowski, R.J., Ibrahim, S.M., Radioembolization of colorectal hepatic metastases using yttrium-90 microspheres (2009) Cancer, 115, pp. 1849-1858
dc.descriptionVogl, T.J., Gruber, T., Balzer, J.O., Repeated transarterial chemoembolization in the treatment of liver metastases of colorectal cancer: Prospective study (2009) Radiology, 250, pp. 281-289
dc.descriptionNishiofuku, H., Tanaka, T., Matsuoka, M., Transcatheter arterial chemoembolization using cisplatin powder mixed with degradable starch microspheres for colorectal liver metastases after FOLFOX failure: Results of a phase I/II study (2013) J Vasc Interv Radiol: JVIR, 24, pp. 56-65
dc.descriptionFiorentini, G., Aliberti, C., Tilli, M., Intra-arterial infusion of irinotecan-loaded drug-eluting beads (DEBIRI) versus intravenous therapy (FOLFIRI) for hepatic metastases from colorectal cancer: Final results of a phase III study (2012) Anticancer Res, 32, pp. 1387-1395. , This phase III trial showed improved survival for the DEBIRI group with similar extrahepatic disease controll. To date, this is the only published randomized controlled trial in this setting
dc.descriptionRichardson, A.J., Laurence, J.M., Lam, V.W., Transarterial chemoembolization with irinotecan beads in the treatment of colorectal liver metastases: Systematic review (2013) J Vasc Interv Radiol: JVIR, 24, pp. 1209-1217
dc.descriptionCeelen, W., Praet, M., Villeirs, G., Defreyne, L., Pattijn, P., Hesse, U., De Hemptinne, B., Initial experience with the use of preoperative transarterial chemoembolization in the treatment of liver metastasis (1996) Acta Chirurgica Belgica, (1), pp. 37-40
dc.descriptionHong, K., McBride, J.D., Georgiades, C.S., Salvage therapy for liver-dominant colorectal metastatic adenocarcinoma: Comparison between transcatheter arterial chemoembolization versus yttrium- 90 radioembolization (2009) J Vasc Interv Radiol, 20, pp. 360-367
dc.descriptionMemon, K., Lewandowski, R.J., Kulik, L., Radioembolization for primary and metastatic liver cancer (2011) Semin Radiat Oncol, 21, pp. 294-302
dc.description(2011) SIR-Spheres (Yttrium-90) Microspheres [Package Insert], , Woburn, MA: Sirtex Medical Inc
dc.descriptionGray, B., Van Hazel, G., Hope, M., Randomised trial of SIRSpheres plus chemotherapy vs. Chemotherapy alone for treating patients with liver metastases from primary large bowel cancer (2001) Ann Oncol: Off J Eur Soc Med Oncol / ESMO, 12, pp. 1711-1720
dc.descriptionHendlisz, A., Van Den Eynde, M., Peeters, M., Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy (2010) J Clin Oncol: Off J AmSoc Clin Oncol, 28, pp. 3687-3694. , A phase III trial of combined modalities with improved benefits in the combination group reinforcing that using both systemic and locoreginal approaches in selected patients results in disease control and survival gains
dc.descriptionSeidensticker, R., Denecke, T., Kraus, P., Matched-pair comparison of radioembolization plus best supportive care versus best supportive care alone for chemotherapy refractory liver-dominant colorectal metastases (2012) Cardiovasc Interv Radiol, 35, pp. 1066-1073
dc.descriptionBenson III, A.B., Geschwind, J.F., Mulcahy, M.F., Radioembolisation for liver metastases: Results from a prospective 151 patient multi-institutional phase II study (2013) Eur J Cancer, 49, pp. 3122-3130
dc.descriptionSharma, R.A., Wasan, H.S., Love, S.B., FOXFIRE: A phase III clinical trial of chemo-radio-embolisation as first-line treatment of liver metastases in patients with colorectal cancer (2008) Clin Oncol (R Coll Radiol), 20, pp. 261-263
dc.descriptionMartin, R.C., Howard, J., Tomalty, D., Toxicity of irinotecaneluting beads in the treatment of hepatic malignancies: Results of a multi-institutional registry (2010) Cardiovasc Intervent Radiol, 33, pp. 960-966
dc.descriptionBorner, M., Castiglione, M., Triller, J., Considerable side effects of chemoembolization for colorectal carcinoma metastatic to the liver (1992) Ann Oncol, 3, pp. 113-115
dc.descriptionMartinelli, D.J., Wadler, S., Bakal, C.W., Cynamon, J., Rozenblit, A., Haynes, H., Kaleya, R., Wiernik, P.H., Utility of embolization or chemoembolization as second-line treatment in patients with advanced or recurrent colorectal carcinoma (1994) Cancer, 74 (6), pp. 1706-1712. , DOI 10.1002/1097-0142(19940915)74:6<1706::AID-CNCR
dc.descriptionLeichman, C.G., Jacobson, J.R., Modiano, M., Daniels, J.R., Zalupski, M.M., Doroshow, J.H., Fletcher, W.S., Macdonald, J.S., Hepatic chemoembolization combined with systemic infusion of 5- fluorouracil and bolus leucovorin for patients with metastatic colorectal carcinoma: A southwest oncology group pilot trial (1999) Cancer, 86 (5), pp. 775-781. , DOI 10.1002/(SICI)1097-0142(19990901)86:5<775::AID
dc.languageen
dc.publisherCurrent Science Ltd
dc.relationCurrent Colorectal Cancer Reports
dc.rightsfechado
dc.sourceScopus
dc.titleNanoknife And Hepatic Embolization For Colorectal Cancer Liver Metastases
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución